The largest database of trusted experimental protocols

Innuprep virus dna rna kit

Manufactured by Analytik Jena
Sourced in Germany

The InnuPREP Virus DNA/RNA Kit is a laboratory equipment designed for the isolation and purification of viral nucleic acids (DNA and RNA) from various sample materials, such as cell culture supernatants, serum, plasma, or other body fluids. The kit utilizes a silica-based membrane technology to efficiently bind, wash, and elute the targeted viral nucleic acids.

Automatically generated - may contain errors

24 protocols using innuprep virus dna rna kit

1

DNA Extraction Protocol for Various Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA of most samples were purified by using the DNeasy Blood & Tissue kit (Qiagen, Hilden, Germany). According to the results of pre-tests (data not shown here), a volume of 80 µL of fresh and frozen blood were used for the nucleic acid extraction and further processing was carried out according to the manufacturer's recommendations. For the nucleic acid extraction of the PBMC and BALF samples, 1 × 106 cells were used. The DNA extraction of the organs (tonsils, heart, bone marrow) was based on 20 mg of each tissue. All samples were eluted in 200 µL elution buffer. In addition, two alternative methods of DNA isolation were performed: To confirm the negative results, a higher number of PBMCs (3 × 106 cells) (modification 1, Supplementary Table 2) and the innuPREP Virus DNA/ RNA Kit (Analytik Jena, Jena, Germany) (modification 2) were used according to the manufacturer´s instructions. RNA/DNA from 3 × 106 cells was eluated in 30 µL nuclease-free water. The samples were stored at − 20 °C until further processing.
+ Open protocol
+ Expand
2

Consensus Genome Sequencing of Viruses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Next-generation sequencing was used to obtain the consensus genomic sequences. The viral nucleic acid was extracted directly from 200 µL cell culture supernatants using the innuPREP Virus DNA/RNA Kit (Analytik Jena, Jena, Germany) according to the manufacturer’s instructions. The reversible terminator sequencing method was used to determine whole genome sequences as described elsewhere in detail [12 (link),13 (link)]. DNA libraries were sequenced on an Illumina® NextSeq 500 sequencer (Illumina, San Diego, CA, USA). Sanger sequencing was carried out to confirm the structure of the tandem-repeat region bridging ORF19 and ORF8. The primer sequences used in PCR amplification and direct sequencing were as follows: 5′-CTCACAGTCTATTGCAGACTGC-3′ and 5′-CACTAGCCTTAGAGAAATGGTG-3′. Dye-labeled fragments were run on ABI 3500 equipment (Delta-Bio Ltd., Szeged, Hungary). Genome assemblies were carried out by combining the sequence files from NGS runs and capillary sequencing runs within the Geneious Prime® 2022.2.2 software (Biomatters Ltd., Auckland, New Zealand). The obtained sequences were deposited in GenBank under the accession numbers OP985603 to OP985634.
+ Open protocol
+ Expand
3

SARS-CoV-2 Viral Load Quantification in Oropharyngeal and Lung Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
To quantify genomic copies in oropharyngeal swabs and 25 mg homogenized lung tissue, RNA was extracted using innuPREP Virus DNA/RNA kit (Analytic Jena) according to the manufacturer’s instructions. qPCR was performed using the NEB Luna Universal Probe One-Step RT–qPCR kit (New England Biolabs) with cycling conditions of 10 min at 55 °C for reverse transcription, 3 min at 94 °C for activation of the enzyme, and 40 cycles of 15 s at 94 °C and 30 s at 58 °C on a qTower G3 cycler (Analytic Jena) in sealed qPCR 96-well plates. Primers and probes were used as previously reported57 . Oligonucleotides (Sequence (5’-3’)): E_Sarbeco_F: ACAGGTACGTTAATAGTTAATAGCGT;
E_Sarbeco_R: ATATTGCAGCAGTACGCACACA;
E_Sarbeco_P1: FAM-ACACTAGCCATCCTTACTGCGCTTCG-BBQ.
+ Open protocol
+ Expand
4

SARS-CoV-2 RNA Detection in Lung Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
To extract RNA from lung tissue, 25 mg of lung tissue was first homogenized in a bead mill (Analytic Jena). RNA was isolated from oral swabs, oropharyngeal swabs, and the homogenized lung tissue using the innuPREP Virus DNA/RNA Kit (Analytik Jena, Jena, Germany). Total SARS-CoV-2 RNA was quantified by quantitative reverse transcription PCR (RT-qPCR), employing the forward primer E_Sarbeco_F1 (ACAGGTACGTTAATAGTTAATAGCGT), the reverse primer E_Sarbeco_R2 (ATATTGCAGCAGTACGCACACA), and the probe E_Sarbeco_P1 (FAM-ACACTAGCCATCCTTACTGCGCTTCG/ZEN/-IBFQ), which targeted the E gene region of SARS-CoV-245 . Subgenomic SARS-CoV-2 RNA transcripts were quantified using the same assay, except that the forward primer was substituted with the primer sgLeadSARSCoV2 (CGATCTCTTGTAGATCTGTTCTC), which targeted the leader sequence of the SARS-CoV-216 (link). The assay was performed on a qTower G3 cycler (Analytik Jena) using the NEB Luna Universal Probe One-Step RT-qPCR Kit (New England Biolabs) and the following cycling conditions: 10 min at 55 °C for reverse transcription, 3 min at 94 °C for activation of the polymerase and 40 cycles of 15 s at 94 °C and 30 s at 58 °C.
+ Open protocol
+ Expand
5

Viral RNA Extraction and SARS-CoV-2 Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
For all samples, viral RNA was extracted using an automatic platform (CyBio FeliX liquid handler) with the innuPREP Virus DNA/RNA Kit (Analytik Jena) as previously described (Crone et al., 2020 (link)). For the dry swabs, 1 ml of 60 % Lysis buffer (diluted with phosphate-buffered saline without calcium chloride or magnesium chloride) was added and left for 10 min before the aliquot of lysis buffer for extraction was processed (Moore et al., 2008 (link)). SARS-CoV-2 RNA (Viral E gene) was detected by real-time RT- PCR (Rowan et al., 2021 ) (Fig. 1).
+ Open protocol
+ Expand
6

SARS-CoV-2 RNA Extraction Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
The RNA extraction of SARS-CoV-2 was performed on the CyBio FeliX liquid handling robot (Analytik Jena), as previously described (Crone et al., 2020 (link)), using the Maxwell HT Viral TNA Kit (Promega), or InnuPREP Virus DNA/RNA Kit (Analytik Jena). Manual RNA extractions were carried out using QIAamp Viral RNA mini kit (Qiagen) as per manufacturer’s protocol. All samples were eluted into 50 μl of kit buffer.
+ Open protocol
+ Expand
7

Influenza A Virus Subtyping from Allantoic Fluids

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was extracted from allantoic fluids that showed hemagglutination activity, using an InnuPREP virus DNA/RNA Kit (Analytik Jena AG, Jena, Germany). The RNA was then subjected to real time RT-PCR-based influenza A viral gene detection with an iTaq Universal SYBR Green One-Step Kit (BioRad, Hercules, CA, USA) and primer sets specific for a conserved region of influenza viral M genes [7 (link)]. The viral gene-positive RNA was reverse-transcribed using SuperScript IV Reverse Transcriptase (Thermo Fisher Scientific, Waltham, MA, USA) for cDNA synthesis. Conventional PCR-based HA and NA subtyping was performed using cDNA and Tks Gflex DNA Polymerase (TaKaRa Bio Inc., Otsu, Japan) with a panel of subtype-specific primer sets [14 (link)].
+ Open protocol
+ Expand
8

Sensitive Detection of FeLV RNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Using innuPREP Virus DNA/RNA Kit (Analytik Jena, Germany), RNA from saliva and plasma samples were extracted according to the manufacturer’s instructions. Previously published primers used were U3F (5′-ACAGCAGAAGTTTCAAGGCC-3′) and G–R (5′-GACCAGTGATCAAGGGTGAG-3′), which targeted the U3-LTR-gag region [8 (link)]. Amplification of RNA from extracted plasma and saliva samples was carried out using one-step Access RT-PCR® (Promega, USA) in a Mastercycler® gradient thermal cycler (Eppendorf, Germany), with an expected amplicon size of 770 bp. The thermal cycling parameters for amplification of FeLV were set as follows: Reverse transcription for 20 min at 45°C and polymerase activation for 1 min at 95°C, followed by 40 cycles of 10 s denaturation at 95°C, 10 s annealing at 52°C, and 30 s extension at 72°C. The amplified PCR products were analyzed by gel electrophoresis using 1.5% (w/v) agarose gel (Vivantis, Malaysia).
+ Open protocol
+ Expand
9

Isolation of DNA from Ovarian Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was isolated from ovarian tissues (20 mg), follicular fluid (200–400 µl), maturation medium (200 µl), oocytes with or without cumulus cells (5–250 oocytes per sample) and parthenotes (5–15 cells per sample) using the innuPREP Virus DNA/RNA Kit (Analytik Jena, Jena, Germany). The DNA/RNA was eluated in 30 or 60 µl nuclease-free water. Samples were stored at − 20 °C until further processing.
+ Open protocol
+ Expand
10

SARS-CoV-2 RNA Quantification in Cell Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was extracted from oropharyngeal swabs and 25 mg homogenized lung tissue using innuPREP Virus DNA/RNA Kit (Analytic Jena, Jena, Germany) according to the manufacturer’s instructions. NEB Luna universal Probe One-Step RT-qPCR Kit (New England Biolabs, Ipswich, MA, United States) was used to perform qPCR with cycling conditions of 10 min at 55°C for reverse transcription, 3 min at 94°C for activation of the enzyme, and 40 cycles of 15 s at 94°C and 30 s at 58°C on a qTower G3 cycler (Analytic Jena, Jena, Germany) in sealed qPCR 96-well plates. To monitor virus growth, SARS-CoV-2 RNA was quantified in cell culture supernatants by RT-qPCR targeting the SARS-CoV-2 E gene, as described previously (Corman et al., 2020 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!